VIVACY & Burgeon

Paris, March 26th, 2025 – Laboratoires VIVACY and Burgeon Biotechnology join forces in a strategic collaboration, combining the expertise of STYLAGE® hyaluronic acid-based dermal fillers with the innovative NOVUMA calcium hydroxyapatite biostimulator. This synergy between two cutting-edge technological platforms aims to deliver premium, innovative, and highly effective skin regenerative solutions, empowering physicians worldwide to meet the evolving needs of their patients with excellence and precision.

'At VIVACY, scientific excellence is at the core of our innovation. By combining our expertise in hyaluronic acid with Burgeon Biotechnology’s advanced research in Calcium Hydroxyapatite, we are taking a synergistic step forward in regenerative aesthetics. This collaboration will enable us to push the boundaries of skin restoration, offering physicians a new generation of injectable solutions that work in harmony with the skin's natural biology.' – Denis Couchourel, Scientific & Medical Director at Laboratoires VIVACY.

A Common Vision: Redefining Regenerative Aesthetics

“NOVUMA is a great opportunity for VIVACY to enter the fast-growing biostimulants market, said Bertrand Frohly, President & CEO at Laboratoires VIVACY. “It answers a growing demand amongst consumers for skin quality and skin regeneration. It is very complementary to our existing STYLAGE® Hyaluronic Acid (HA) portfolio where we have a clear leadership in Europe. We will deploy NOVUMA in the coming months across Europe first and expand to other geographies with one objective in mind: offer our physician partners the best technologies to meet patients’ expectations for safe, effective solutions that improve their appearance and the quality of their skin.”

Levent Mete Özgürbüz, the Founder of Burgeon Biotechnology, commented: ‘’We are excited to announce a significant strategic partnership on a global scale. Thanks to our innovative technologies, pioneering vision, and proven international success, we have established a strategic partnership with VIVACY, one of the industry’s leading players. With this collaboration, we will continue to lead the industry and deliver innovative solutions. This partnership will further strengthen and expand the innovation, comprehensiveness, and effectiveness of our products and solutions. I am confident that together we will achieve global successes while developing new solutions that will define the standards of the future.’’

Commitment to Excellence in Regenerative Aesthetics

This partnership reinforces VIVACY’s and Burgeon’s commitment to pioneering aesthetic regenerative medicine with superior tools, providing immediate, effective and scientifically proven results that support skin regeneration and well-ageing at every stage of life.

For more information on Laboratoires VIVACY and Burgeon Biotechnology, visit www.vivacy.com or www.burgeon.me.

MK1244 vA